Robotic Cytoreductive Surgery With Heated Intraperitoneal Chemotherapy

Am Surg. 2023 Aug;89(8):3476-3477. doi: 10.1177/00031348231161709. Epub 2023 Mar 3.

Abstract

Cytoreductive surgery with heated intraperitoneal chemotherapy (CRS-HIPEC) is traditionally an open operation given the dissection required during cytoreduction. There are reports of minimally invasive HIPECs, but CRS to an accepted completeness of cytoreduction (CCR) has been described less frequently. We report a patient with metastatic low-grade mucinous appendiceal neoplasm (LAMN) to the peritoneum treated with robotic CRS-HIPEC. A 49-year-old male presented to our center following a laparoscopic appendectomy at an outside facility with final pathology showing LAMN. He had a peritoneal cancer index (PCI) score of 5 determined by diagnostic laparoscopy. Given the small amount of peritoneal disease, he was deemed a candidate for robotic CRS-HIPEC. Cytoreduction was completed robotically with a CCR score of 0. He then received HIPEC with mitomycin C. This case shows the feasibility of robotic-assisted CRS-HIPEC for select LAMNs. When appropriately selected, we advocate for the continued use of this minimally invasive approach.

Keywords: appendiceal cancer; cytoreductive surgery with heated intraperitoneal chemotherapy; intra-abdominal mucinous neoplasms; minimally invasive surgery.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma, Mucinous* / pathology
  • Adenocarcinoma, Mucinous* / surgery
  • Antineoplastic Combined Chemotherapy Protocols
  • Appendiceal Neoplasms* / pathology
  • Appendiceal Neoplasms* / surgery
  • Combined Modality Therapy
  • Cytoreduction Surgical Procedures
  • Humans
  • Hyperthermia, Induced*
  • Male
  • Middle Aged
  • Peritoneal Neoplasms* / pathology
  • Peritoneal Neoplasms* / surgery
  • Retrospective Studies
  • Robotic Surgical Procedures*